head and neck cancer Press Release

Title Picture
12/06/2018 - 21:29
Update on the Phase III EAGLE trial of Imfinzi and tremelimumab in advanced head and neck cancer
AstraZeneca's picture
AstraZeneca
12/06/2018 - 12:33
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York
Biolinerx's picture
Biolinerx
11/16/2018 - 05:55
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
11/15/2018 - 19:49
Standard chemo still most effective for throat cancers caused by HPV
Cancer Research UK's picture
Cancer Research UK
11/15/2018 - 19:43
Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds
University of Birmingham's picture
University of B...
11/09/2018 - 05:02
First presentation of LENVIMA and KEYTRUDA combination data in patients with metastatic non-small cell lung cancer, metastatic melanoma and metastatic urothelial carcinoma from Study 111/KEYNOTE-146
EISAI's picture
EISAI
11/07/2018 - 07:07
Soligenix Announces Poster at the 2018 American Society of Microbiology Microbe Conference in Atlanta, Georgia
Soligenix's picture
Soligenix
11/04/2018 - 22:31
People in Rural Areas Have Much Higher Risk of Larynx Cancer
Fox Chase's picture
Fox Chase
10/30/2018 - 03:20
Fox Chase Researchers Selected to Present at ECOG-ACRIN Young Investigator Symposium
Fox Chase's picture
Fox Chase
10/29/2018 - 21:40
NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC's AI and Transgene's myvac platform
NEC's picture
NEC
10/25/2018 - 06:59
Head and Neck Cancer Survivors Have Increased Risk of Suicide
Saint Louis University's picture
Saint Louis Uni...
10/23/2018 - 18:13
CEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES
Cel-Sci's picture
Cel-Sci
10/23/2018 - 02:22
AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
AstraZeneca's picture
AstraZeneca
10/10/2018 - 20:00
CEL-SCI ANNOUNCES WARRANTS TO EXPIRE ON OCTOBER 11, 2018
Cel-Sci's picture
Cel-Sci
10/09/2018 - 09:02
AstraZeneca presents advances in improving treatment options for ovarian and lung cancer patients at ESMO 2018 Congress
AstraZeneca's picture
AstraZeneca
10/04/2018 - 07:42
Soligenix Announces Poster Presentations of its Ricin Vaccine and Dusquetide Oral Mucositis Programs at the 2018 NORD Rare Diseases and Orphan Products Breakthrough Summit
Soligenix's picture
Soligenix
09/27/2018 - 20:42
FDA approves first treatment for advanced form of the second most common skin cancer
FDA's picture
FDA
09/25/2018 - 22:45
Positive results from the 6-months Interim analysis of the phase IIa clinical study in high grade cervical dysplasia provides Proof-of-Concept for Vaccibodys immunotherapy platform.
Vaccibody's picture
Vaccibody
09/24/2018 - 21:10
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III lung cancer
AstraZeneca's picture
AstraZeneca
09/23/2018 - 19:29
European Commission approves Imfinzi for locally-advanced, unresectable NSCLC
AstraZeneca's picture
AstraZeneca
09/18/2018 - 13:14
Star-studded cast join forces to show cancer it's payback time
Cancer Research UK's picture
Cancer Research UK
09/14/2018 - 03:39
CEL-SCI RECEIVES $5.4 MILLION FROM WARRANT EXERCISES
Cel-Sci's picture
Cel-Sci
09/12/2018 - 14:52
New Immunotherapy Approach Found in Superagonist Interleukin-15 Complex
Roswell Park Cancer Institute's picture
Roswell Park Ca...
09/11/2018 - 20:03
Scientists Map Interactions between Head and Neck Cancer and HPV Virus
Gladstone Institutes's picture
Gladstone Institutes
09/05/2018 - 18:21
NIH SELECTS CEL-SCI's LEAPS RHEUMATOID ARTHRITIS VACCINE FOR COMMERCIALIZATION ACCELERATOR PROGRAM
Cel-Sci's picture
Cel-Sci
08/29/2018 - 05:03
Soligenix to Present at the 2018 ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
Soligenix's picture
Soligenix
08/14/2018 - 16:27
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
NIH's picture
NIH
08/03/2018 - 01:55
UPMC to Host Inaugural Patient Symposium on Head and Neck Cancer
UPMC's picture
UPMC
07/27/2018 - 08:31
Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
07/19/2018 - 07:20
Soligenix Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Soligenix's picture
Soligenix
07/13/2018 - 14:44
Board of Associates Presents Fox Chase Cancer Center with a Generous Gift
Fox Chase's picture
Fox Chase
07/12/2018 - 22:40
CEL-SCI REPORTS ON NYSE AMERICAN NONCOMPLIANCE NOTICE AND COMPLIANCE PLAN
Cel-Sci's picture
Cel-Sci
07/11/2018 - 17:30
New Information About Head and Neck Cancer Outlined in Molecular Determinants of Head and Neck Cancer, 2nd Edition
Fox Chase's picture
Fox Chase
07/02/2018 - 01:27
Computer Algorithm Maps Cancer Resistance to Drugs, Therapy
Johns Hopkins Health System's picture
Johns Hopkins H...
07/01/2018 - 20:49
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
06/27/2018 - 14:10
CEL-SCI WINS BREACH OF CONTRACT RULING AGAINST CLINICAL RESEARCH ORGANIZATION INVENTIV, NOW KNOWN AS SYNEOS HEALTH
Cel-Sci's picture
Cel-Sci
06/08/2018 - 05:14
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENTS FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
05/25/2018 - 01:08
Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable Stage III non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
05/22/2018 - 04:13
CEL-SCI CORPORATION TO PRESENT AT THE 8TH ANNUAL LD MICRO INVITATIONAL
Cel-Sci's picture
Cel-Sci
05/14/2018 - 09:46
New Computational Strategy Designed for More Personalized Cancer Treatment
JohnsHopkinsUniversity's picture
JohnsHopkinsUni...
05/02/2018 - 07:34
CEL-SCI CORPORATION ANNOUNCES UPCOMING INVESTOR CONFERENCE PRESENTATIONS
Cel-Sci's picture
Cel-Sci
04/23/2018 - 22:36
AstraZeneca reports results from the ARCTIC trial in third-line non-small cell lung cancer
AstraZeneca's picture
AstraZeneca
04/20/2018 - 04:07
Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018
Celldex's picture
Celldex
04/17/2018 - 13:15
North Memorial Health, Delta Dental Partner to Host HPV-Associated Head and Neck Cancer Awareness Event
North Memorial Medical Center's picture
North Memorial ...
04/17/2018 - 07:48
Fox Chase Cancer Center Raises Awareness on Risk Factors and Signs of Head and Neck Cancer
Fox Chase's picture
Fox Chase
04/16/2018 - 01:38
Celldex's METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
Celldex's picture
Celldex
04/09/2018 - 04:34
CEL-SCI CORPORATION TO PRESENT AT THE MICROCAP CONFERENCE
Cel-Sci's picture
Cel-Sci
04/05/2018 - 13:57
NIH researchers use genomics to set squamous cell carcinomas apart from other cancers
NIH's picture
NIH
03/28/2018 - 08:53
Free Head and Neck Cancer Screenings Offered
Henry Ford Health System's picture
Henry Ford Heal...
03/10/2018 - 22:57
AstraZeneca provides update on MYSTIC trial timeline
AstraZeneca's picture
AstraZeneca
03/07/2018 - 10:09
Slow-release hydrogel aids immunotherapy for cancer
RiceUniv's picture
RiceUniv
02/22/2018 - 09:35
Study identifies predictors of immunotherapy response in head and neck cancer
Dana Farber's picture
Dana Farber
02/19/2018 - 14:59
Dr. Daruka Mahadevan (left) and Eric Weterings examine cancer cells in a petri dish. Mahadevan is director of the UA Cancer Center Early Phase Clinical Trials Program. (Photo: Kris Hanning/UAHS, ABOR, BioCommunications)
ArizonaUniv's picture
ArizonaUniv
02/09/2018 - 09:09
Jean Kozempel Receives Oncology Award from the American Physical Therapy Association
Fox Chase's picture
Fox Chase
02/05/2018 - 14:21
CEL-SCI TO PRESENT AT 2018 BIO CEO & INVESTOR CONFERENCE
Cel-Sci's picture
Cel-Sci
02/05/2018 - 09:33
Physical Inactivity Linked to Higher Risk of Lung, Head/Neck Cancers
Roswell Park Cancer Institute's picture
Roswell Park Ca...
01/31/2018 - 03:46
Pro Football Hall of Famer and Cancer Survivor Jim Kelly Joins Merck to Challenge America to Raise Funds for the Cancer Community
Merck's picture
Merck
01/30/2018 - 15:54
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENT FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
01/19/2018 - 13:40
UCLA study describes structure of tumor herpes virus associated with Kaposis sarcoma
UCLA's picture
UCLA
01/16/2018 - 11:34
CEL-SCI ANNOUNCES ADJUSTMENT TO WARRANT EXERCISE PRICE
Cel-Sci's picture
Cel-Sci